Prothena Corporation plc

+1.75 (+6.28%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)1.39B
Current PE20.55
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$17.18 Million
Adjusted EPS-$0.52
See more estimates
10-Day MA$27.29
50-Day MA$27.17
200-Day MA$42.02
See more pivots

Prothena Corporation plc Stock, NASDAQ:PRTA

77 Sir John Rogersons Quay, Grand Canal Docklands, Dun Laoghaire, Dublin 2
Phone: +353.1.236.2500
Number of Employees: 82


Prothena Corp. Plc is a clinical-stage neuroscience company. It focuses on the discovery and development of novel therapies to change the course of devastating diseases. The firmâ??s clinical pipeline includes both wholly-owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, Alzheimerâ??s disease, Parkinsonâ??s disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.